Introduction {#section1-2192568219869330}
============

Surgical site infections (SSIs) are extremely burdensome to the patients, a leading cause of morbidity, and a major cause of readmission with longer lengths of stay after spinal surgery.^[@bibr1-2192568219869330]^ Although meticulous prophylactic surgical practice is crucial to avoid such incidences, there is always some incidence of infection in or around the area that has been instrumented in surgery.^[@bibr1-2192568219869330],[@bibr2-2192568219869330]^ Many authors have summarized the key prevention and postsurgical management techniques for SSI in spine surgery; however, because of the varied nature of surgical practices and the numerous factors involved, the focus has been on overall preventative and management measures.^[@bibr2-2192568219869330][@bibr3-2192568219869330]-[@bibr4-2192568219869330]^ In addition, SSIs in medical care are deemed as "never events" and their occurrence is considered to be influenced by the hospital policies and procedures. Such an outlook toward infection leads many practitioners and hospital system to bundle as many potential measures and/or increase the intensity (dosage in some cases) of individual measures, some to the point of redundancy.^[@bibr5-2192568219869330],[@bibr6-2192568219869330]^ The result of such practices is no less than controversial as can be exemplified simply by the previously cited ranges in prevalence of SSI.^[@bibr7-2192568219869330]^ Therefore, it is very useful to consistently evaluate the results of all recently published clinical practice, in an attempt to corroborate or nullify isolated variables into being effective or not. Few such variables during management of SSI are implant removal rate, common bacterial organisms found, time of onset, ratio of superficial to deep infection, and so on. Thus, the objective of this literature review is to summarize the findings on implant removal rate, common bacterial organisms found, time of onset, ratio of superficial to deep infection, and regurgitating the prevalence among all the retrospective and prospective studies on management and/or characterization of SSI.

Methods {#section2-2192568219869330}
=======

The general method utilized for the literature review was adopted from Cochrane collaboration. [Table 1](#table1-2192568219869330){ref-type="table"} shows the search strategy that was developed for the PubMed database, for the period 2000-2018. Title and abstracts were reviewed to shortlist articles for full length review. The shortlisting was followed by full-text review of all references that appeared to retrospectively or prospectively address the key SSI management techniques at an event of surgical site infection.

###### 

Medline Search Strategy Using PubMed.

![](10.1177_2192568219869330-table1)

  --------------------------------------------------------------------
  <http://www.ncbi.nlm.nih.gov/pubmed/advanced>

  MeSh terms:\
   1. Surgical Wound Infection/surgery \[mh\]\
  \[mh\] denotes a Medical Subject Heading (MeSH) term ("exploded");

  AND (Boolean operator)

  Terms for area of interest:\
   1. Spine \[tw\]\
   2. Spinal \[tw\]\
  \[tw\] denotes text word;

  NOT (Boolean operator)

  Terms for exclusion:\
   1. Cord \[ti\]\
   2. Case Reports \[ptyp\]\
  \[ti\] denotes title;\
  \[ptyp\] denotes publication type;

  AND (Boolean operator)

  Terms for date range:\
   1. "2000/01/01"\[PDat\]: "2018/12/31"\[PDat\]\
  \[PDat\] denotes publication date;
  --------------------------------------------------------------------

Results {#section3-2192568219869330}
=======

A total of 79 full-text articles were retrieved after screening through titles and abstracts. Of these, only 49 articles were found relevant, and were used for the synthesis below.^[@bibr8-2192568219869330][@bibr9-2192568219869330][@bibr10-2192568219869330][@bibr11-2192568219869330][@bibr12-2192568219869330][@bibr13-2192568219869330][@bibr14-2192568219869330][@bibr15-2192568219869330][@bibr16-2192568219869330][@bibr17-2192568219869330][@bibr18-2192568219869330][@bibr19-2192568219869330][@bibr20-2192568219869330][@bibr21-2192568219869330][@bibr22-2192568219869330][@bibr23-2192568219869330][@bibr24-2192568219869330][@bibr25-2192568219869330][@bibr26-2192568219869330][@bibr27-2192568219869330][@bibr28-2192568219869330][@bibr29-2192568219869330][@bibr30-2192568219869330][@bibr31-2192568219869330][@bibr32-2192568219869330][@bibr33-2192568219869330][@bibr34-2192568219869330][@bibr35-2192568219869330][@bibr36-2192568219869330][@bibr37-2192568219869330][@bibr38-2192568219869330][@bibr39-2192568219869330][@bibr40-2192568219869330][@bibr41-2192568219869330][@bibr42-2192568219869330][@bibr43-2192568219869330][@bibr44-2192568219869330][@bibr45-2192568219869330][@bibr46-2192568219869330][@bibr47-2192568219869330][@bibr48-2192568219869330][@bibr49-2192568219869330][@bibr50-2192568219869330][@bibr51-2192568219869330][@bibr52-2192568219869330][@bibr53-2192568219869330][@bibr54-2192568219869330][@bibr55-2192568219869330]--[@bibr56-2192568219869330]^ Below is the summary of their findings. Relevancy was determined purely based on if the articles answered any one of the following: (1) implant removal rate, (2) common bacterial organisms found following infection, (3) time of onset, and (4) ratio of superficial to deep infection. Furthermore, only prospective or retrospective studies were included.

Implant Removal/Retention Rate {#section4-2192568219869330}
------------------------------

In a study by Maruo et al,^[@bibr16-2192568219869330]^ 154 of 197 (78%) of SSIs were eradicated within 90 days, of which 76% were also able to retain the implants. Forty-three of 197 (22%), which were not managed within 90 days, were considered failure in management of SSI.^[@bibr16-2192568219869330]^ However, 93% of these 78% aforementioned were superficial infections.^[@bibr16-2192568219869330]^ A few studies had close to 0% to 10% implant removal.^[@bibr17-2192568219869330][@bibr18-2192568219869330][@bibr19-2192568219869330]-[@bibr20-2192568219869330]^ Yin et al^[@bibr21-2192568219869330],[@bibr22-2192568219869330]^ in their 2010-2014 series were able to retain implant in 40 of 41 cases of late onset SSI. In contrast, many other studies required implant removal on all or majority of cases, for example, 13 of 13, 26 of 26, 20 of 20, 10 of 10 (100%), and so on.^[@bibr23-2192568219869330][@bibr24-2192568219869330][@bibr25-2192568219869330][@bibr26-2192568219869330]-[@bibr27-2192568219869330]^ Di Silvestre et al,^[@bibr28-2192568219869330]^ in a long-interval SSI detection period (3 years), found the need for 100% removal of implants in all 15 SSI cases among the 540 cases operated upon. Nevertheless, other authors such as Kanayama et al,^[@bibr29-2192568219869330]^ even at short-interval SSI detection period, observed 8 of 8 (100%) in need of hardware removal. Another study looking at a specific bacterial species reported 31 of 68 (46%) had need for complete removal of implant, and additional 13 of 68 (19%) has partial implant removal.^[@bibr30-2192568219869330]^ Among few studies with significant yet not majority implant removal proportion, one identified 61 of 84 cases (73%) had implant retention with deep SSI, and 48 of 48 (100%) with superficial SSI.^[@bibr31-2192568219869330]^ Similarly, other cohorts showed at least 21 of 83 (25%), 26 of 44 (58%), 22 of 42 (52%) needing implant removal.^[@bibr32-2192568219869330][@bibr33-2192568219869330]-[@bibr34-2192568219869330]^

Bacterial Genus/Species {#section5-2192568219869330}
-----------------------

The common type of bacterial infection was methicillin-resistant *Staphylococcus aureus* (MRSA): 10 of 14 (71%), 11 of 18 (61%), 7 of 20 (35%), 5 of 10 (50%); methicillin-resistant *Staphylococcus epidermidis* (MRSE): 9 of 21 (43%); coagulase-negative staphylococci (possibly *Staphylococcus epidermidis*): 12 of 27 (45%), 3 of 9 (33%); *Staphylococcus aureus*: 31 of 51 (61%), 7 of 17 (41%), 6 of 20 (30%), 3 of 10 (30%); polymicrobial: 7 of 17 (41%); methicillin-resistant coagulase-negative staphylococci (MRCNS): 1 of 10 (10%); *Aspergillus fumigatus* (a. fumigatus): 1 of 10 (10%); gram negative, anaerobic such as *Propionibacterium acnes*, antibiotic-resistant strains: 5 of 9 (83%).^[@bibr17-2192568219869330],[@bibr18-2192568219869330],[@bibr20-2192568219869330],[@bibr23-2192568219869330]-[@bibr24-2192568219869330],[@bibr29-2192568219869330],[@bibr35-2192568219869330][@bibr36-2192568219869330][@bibr37-2192568219869330]-[@bibr38-2192568219869330]^

SSI Onset Time {#section6-2192568219869330}
--------------

Studies that specified the onset interval of SSI, early onset (\<30 days) constituted 162 of 225 (72%), 7 of 14 (50%), 13 of 20 (65%), 33 of 41 (80.5% skewed proportion; because authors didn\'t report late onset SSI), 42 of 51 (82% skewed).^[@bibr16-2192568219869330],[@bibr19-2192568219869330],[@bibr24-2192568219869330],[@bibr37-2192568219869330],[@bibr39-2192568219869330]^ Delayed onset (30 days to 1 year) constituted 57 of 225 (25%), 5 of 14 (35%), 3 of 20 (15%), 8 of 41 (19.5% skewed), and 9 of 51 (17.6 skewed), whereas late onset (\>1 year) constituted 6 of 225 (3%), 2 of 14 (15%), and 4 of 20 (20%).^[@bibr16-2192568219869330],[@bibr19-2192568219869330],[@bibr24-2192568219869330],[@bibr37-2192568219869330],[@bibr39-2192568219869330]^

Deep Versus Superficial SSI {#section7-2192568219869330}
---------------------------

Another variable that existed was identification of deep versus superficial infection. Some recorded the distribution, whereas others focused on deep SSI (via exclusion of superficial SSI). Deep SSI constituted 2 of 4 (50%), 11 of 22 (50%), 22 of 29 (76%), 10 of 17 (58%), 29 of 54 (53%), 64 of 78 (82%), 53 of 104 (51%), 1409 of 2344 (60%), 12 of 27 (45%), 7 of 9 (77%), 2 of 2 (100%), 84 of 132 (64%), 69 of 79 (87%) among various studies, whereas superficial SSI constituted 2 of 4 (50%), 11 of 22 (50%), 7 of 29 (24%), 7 of 17 (42%), 24 of 54 (47%), 13 of 78 (16.7%), 41 of 104 (39%), 867 of 2344 (37%), 15 of 27 (55%), 2 of 9 (23%), 48 of 132 (36%), 10 of 79 (13%).^[@bibr25-2192568219869330],[@bibr26-2192568219869330],[@bibr29-2192568219869330],[@bibr31-2192568219869330],[@bibr36-2192568219869330],[@bibr40-2192568219869330][@bibr41-2192568219869330][@bibr42-2192568219869330][@bibr43-2192568219869330][@bibr44-2192568219869330]-[@bibr45-2192568219869330]^

SSI Incidence Rate {#section8-2192568219869330}
------------------

The SSI incidence rate itself varied and is presented in [Table 2](#table2-2192568219869330){ref-type="table"}.

###### 

Prevalence of Surgical Site Infections (SSI) Among Various Studies.

![](10.1177_2192568219869330-table2)

  --------------------------------------------------------------------------------------------------------------------------------------------
  SSI (%)   No. of SSIs   No. of Patients   Start Year   End Year   Country   Type
  --------- ------------- ----------------- ------------ ---------- --------- ----------------------------------------------------------------
  1.9       16            824               1997         2002       USA       Posterior spinal fusion (n = 7)\
                                                                              360-degree fusion (n = 9)

  2.9       22            854               1986         2001       USA       Posterior spinal fusion (n = 22)

  4         63            1532              2003         2005       USA       Posterior spinal fusion (n = 36)

  9.8       11            112               2003         2011       USA       Posterior spinal fusion of cervical spine (n = 11)

  5.8       78            1347              2006         2008       USA       Scoliosis with posterior instrumentation (n = 78)

  11.1      42            379               1996         2010       USA       Growth rod surgeries (n = 42)

  3.9       5             127               2001         2013       USA       Posterior spinal fusion of cervical spine (n = 5)

  3.8       216           5761              2003         2013       USA       Posterior spinal fusion (n = 184)

  10.3      44            428               1980         2010       USA       Scoliosis with posterior instrumentation (n = 44)

  5.2       29            551               2008         2012       USA       Posterior spinal fusion of cervical spine (n = 29)

  1.4       26            1771              1995         2006       USA       Scoliosis with posterior instrumentation (n = 26)

  4.2       132           3174              1996         2005       USA       Posterior spinal fusion (n = 105)

  1.9       17            854               NA           NA         USA       Posterior spinal fusion (n = 17)

  12.7      40            314               2008         2011       USA       Posterior spinal fusion (n = 40)

  1.22      45            3673              2007         2009       USA       Posterior spinal fusion (n = 45)

  3.4       272           7991              2005         2009       USA       Posterior spinal fusion (n = 272)

  12.15     41            334               NA           NA         USA       Scoliosis with posterior instrumentation (n = 41)

  3.2       45            1400              2008         2010       USA       Posterior spinal fusion (n = 45)

  6.1       53            874               2006         2008       USA       Scoliosis with posterior instrumentation (n = 53)

  3.5       176           5023              2005         2009       USA       Posterior spinal fusion (n = 176)

  1.5       67            4464              2011         2014       USA       Posterior spinal fusion (n = 67)

  5.6       290           5170              2003         2009       USA       Posterior spinal fusion (n = 290)

  13        7             54                NA           NA         USA       Posterior spinal fusion (n = 7)

  1.9       999           52567             2005         2012       USA       Posterior spinal fusion (n = 999)

  4.12      40            971               2012         2013       USA       Posterior spinal fusion (n = 40)

  2         16            799               2013         2014       USA       Posterior spinal fusion (n = 16)

  0.7       586           83658             2013         2014       USA       Posterior spinal fusion (n = 586)

  0.2       39            19706             2008         2009       USA       Posterior spinal fusion (n = 39)

  6         6             100               2013         2014       UK        Posterior spinal fusion (n = 6)

  1.4       11            786               2004         2006       Taiwan    Posterior spinal fusion (n = 9)

  11.6      54            466               2008         2011       Spain     Posterior spinal fusion (n = 54)

  0.9       32            3457              2000         2009       Korea     Posterior spinal fusion (n = 3)\
                                                                              Posterior lumbar interbody fusion with pedicle screws (n = 29)

  0.6       11            1597              1997         2004       Japan     Posterior decompression (n = 3)\
                                                                              Posterior spinal fusion (n = 8)

  6.3       14            223               2005         2006       Japan     Posterior spinal fusion (n = 11)

  4.6       16            345               2005         2011       Japan     Posterior spinal fusion (n = 16)

  4.4       18            409               2007         2013       Japan     Posterior spinal fusion (n = 18)

  3.15      21            665               2007         2014       Japan     Posterior spinal fusion (n = 21)

  2.8       16            564               2010         2011       Japan     Posterior spinal fusion (n = 16)

  7.5       3             40                2011         2012       Greece    Posterior spinal fusion (n = 20)

  2.04      1             49                2013         2014       France    Posterior spinal fusion (n = 1)

  9.70      68            698               2002         2006       France    Scoliosis with posterior instrumentation (n = 58)

  10.3      51            496               2007         2012       France    Scoliosis with posterior instrumentation (n = 51)

  5.2       14            270               1994         1998       Canada    Posterior spinal fusion (n = 10)\
                                                                              360-degree fusion (n = 4)

  2.77      15            540               1993         2005       Brazil    Posterior spinal fusion (n = 15)
  --------------------------------------------------------------------------------------------------------------------------------------------

Discussion {#section9-2192568219869330}
==========

In majority of the studies, patients who presented with SSI had to be readmitted for irrigation and debridement and implant removal/replacement. However, there were also fewer studies where revision surgery for SSI was not necessary in all the patients, for example, 9 of 14 (64%) with mean hospital stay of 43 days.^[@bibr39-2192568219869330]^ Key steps for management included irrigation and debridement, vacuum-assisted wound closure (VAC) in 25% and more cases, and variable term antibiotics administration (both intravenous and oral).^[@bibr17-2192568219869330][@bibr18-2192568219869330][@bibr19-2192568219869330]-[@bibr20-2192568219869330],[@bibr24-2192568219869330],[@bibr28-2192568219869330],[@bibr31-2192568219869330],[@bibr36-2192568219869330],[@bibr39-2192568219869330],[@bibr44-2192568219869330],[@bibr46-2192568219869330][@bibr47-2192568219869330][@bibr48-2192568219869330][@bibr49-2192568219869330][@bibr50-2192568219869330][@bibr51-2192568219869330][@bibr52-2192568219869330]-[@bibr53-2192568219869330]^

Many authors concluded that eradication of deep SSIs was not possible without complete removal of spinal implants. In addition, repeated site debridement could not eradicate SSI either while the implants (pedicular and/or interbody constructs) were retained, and therefore removal in most or all patients was later necessary.^[@bibr23-2192568219869330],[@bibr27-2192568219869330]^ Furthermore, one of this study also disclosed that the average number of surgeries required for infection treatment to be 4 (range 1-16), leading up to an average cost of SSI treatment range from quarter of a million to just shy of a million dollars per patient.^[@bibr27-2192568219869330]^ A smaller proportion of such recovering patients still presented with residual back pain and reduced activity.^[@bibr23-2192568219869330]^ To reconcile differences in practices (complete versus partial removal of implants), recently Khanna et al^[@bibr54-2192568219869330]^ presented a thorough retrospective analysis on implant retention and its association with antibiotic administration and onset interval. They associated delayed onset or late onset SSI patient with higher risk of SSI recurrence in absence of hardware removal. Most of their cases with early or delayed SSI were able to retain implants with early aggressive debridement.^[@bibr54-2192568219869330]^ When comparing the type of SSI (deep vs superficial, and late vs delayed vs early onset SSI) among these studies, eradicating deep SSI with delayed and late onset infections were most difficult, with majority needing repeated debridement and drainage.^[@bibr16-2192568219869330],[@bibr29-2192568219869330]^ A common problem was that of late onset SSI with low virulent p. acnes. Being low virulent bacteria, it remained undetected in the early intervals leading to widespread biofilm formation on the implants, later leading to a resilient onset of SSI.^[@bibr30-2192568219869330]^ For instance, because of repeated detection of *P acnes*, 8 of 68 (11.7%) patients underwent multiple revision surgeries in one series.^[@bibr31-2192568219869330]^ An exception to this trend was the study by Yin et al,^[@bibr21-2192568219869330]^ where they retained implants in most cases with late-onset SSI (*S aureus* was the common organism). It should be noted that they also noticed negative culture results in seven patients with late onset SSI (hence the underlying risk of undetected growth of organism) and one with hardware loosening due to recurrence of infection.^[@bibr21-2192568219869330]^

Most common organism detected were MRSA, MRSE, *S epidermis*, *S aureus*, and *P acnes*; nonetheless there were also others like polymicrobial and gram negative cited in the studies.^[@bibr17-2192568219869330],[@bibr18-2192568219869330],[@bibr20-2192568219869330],[@bibr23-2192568219869330],[@bibr24-2192568219869330],[@bibr29-2192568219869330],[@bibr35-2192568219869330][@bibr36-2192568219869330][@bibr37-2192568219869330]-[@bibr38-2192568219869330]^ Authors noted that gram negative infection was common in early infections, whereas later ones presented with *S aureus*, *P acnes*, and so on.^[@bibr39-2192568219869330]^ In many studies, the interval of infection onset was limited to early, that is, \<30 days, \<90 days, between 30 and 90 days, or \<6 months for detection of SSI, or was not mentioned.^[@bibr24-2192568219869330],[@bibr27-2192568219869330],[@bibr55-2192568219869330],[@bibr56-2192568219869330]^ In few, the authors specifically looked at late onset infection with average occurrence about 70 months with 15 of 540 index cases (2.77%).^[@bibr28-2192568219869330]^ Longer term studies, extending over 6 years also concluded 56 to 80 months as average SSI detection length with total incidence of 68 *P acnes* cases of 698 index cases (9.7%).^[@bibr30-2192568219869330]^ There were higher proportion of deep SSI over superficial SSI in most studies. Higher incidence of failure in management of SSI (recurrence) were seen with iliac fixation, polymicrobial infections, *P acnes* infections (of which many often were delayed or late onset), and \>6-level fixation.^[@bibr16-2192568219869330]^

As shown in [Table 2](#table2-2192568219869330){ref-type="table"}, the SSI incidence rate could be argued to be a result of varied spinal surgical practices and reporting methods, including differences in prophylactic measures, quality of hospital facilities, duration of follow-up, and the country of practice at the minimum.^[@bibr7-2192568219869330],[@bibr57-2192568219869330][@bibr58-2192568219869330][@bibr59-2192568219869330][@bibr60-2192568219869330]-[@bibr61-2192568219869330]^

Besides physical examination, common diagnostic tools used to detect infection are imaging (computed tomography and magnetic resonance imaging), blood culture, C-reactive protein, erythrocyte sedimentation rate, white blood cell count, and other inflammatory biomarkers. Many of these methods provide high positive predictive value but relatively lower negative predictive value. Lower negative predictive value implies that there still exist possibilities of hidden contamination, which presents itself as full-blown infection at a later interval, as delayed or late onset SSI. Furthermore, unlike superficial infection (localized to the skin and subcutaneous tissue), most deep infections lack superficial presentations making their diagnosis solely presumptive. Thus, a more cautious pathway in management of late-onset SSI may be complete removal or replacement of implants in such cases. Some authors of these studies concluded that attempts made to retain implants only lead to multiple reoperations, higher costs, and patient burden.^[@bibr27-2192568219869330]^ Recent studies on identification of occult infection led hardware loosening, and propensity of bacterial infestation and growth on implant surfaces outside and inside the theatre provides further evidences of levels of higher uncertainty (of subsequent infection) involved in the management of SSI and its preventive measures.^[@bibr62-2192568219869330][@bibr63-2192568219869330][@bibr64-2192568219869330][@bibr65-2192568219869330][@bibr66-2192568219869330][@bibr67-2192568219869330]-[@bibr68-2192568219869330]^

Conclusion {#section10-2192568219869330}
==========

Based on the data presented in myriads of prospective and retrospective studies, it is perhaps prudent to replace or remove the existing implants for management of late onset deep SSI. Additionally, although a wide range of SSI incidence rates have been observed, there exists uniformity in the type of bacterial organisms being reported.
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